<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
    <channel>
        <title>Abbott Amulet Update?</title>
        <description> I&amp;#039;m wondering if anyone has any knowledge of the latest thinking about the Abbott Aplatzer Amulet LAA ocluder device. I just noticed this press release (dated Aug. 16, 2021) from Abbott: 

Abbott&amp;#039;s Amplatzer Amulet Device Approved by FDA

In view of recent (and earlier) discussions on this forum about post-Watchman aspirin/NOAC use, am particularly curious about their claim, &amp;quot;Before this approval, the only minimally invasive option for LAA occlusion for U.S. physicians and their patients was a solution with a single component to seal the LAA that requires blood-thinning drugs to heal and additional patient monitoring to ensure closure. In contrast, Abbott&amp;#039;s Amulet uses dual-seal technology to completely and immediately seal the LAA. Amulet recipients do not need to use blood-thinning medication following the procedure.&amp;quot;

Thanks and best wishes, Lance</description>
        <link>https://www.afibbers.org/forum/read.php?9,182966,182966#msg-182966</link>
        <lastBuildDate>Wed, 23 Sep 2026 21:23:43 +0000</lastBuildDate>
        <generator>Phorum 5.2.23</generator>
        <item>
            <guid>https://www.afibbers.org/forum/read.php?9,182966,182978#msg-182978</guid>
            <title>Re: Abbott Amulet Update?</title>
            <link>https://www.afibbers.org/forum/read.php?9,182966,182978#msg-182978</link>
            <description><![CDATA[ Found this today. Sponsored by Boston Scientific, manufacturer of the Watchman FLX, but might be of interest.<br />
<br />
All best, Lance<br />
<br />
Saturday, November 6<br />
<b>LAA Closure | <a href="https://www.bostonscientific.com/en-US/medical-specialties/interventional-cardiology/tct2021.html"  rel="nofollow">Left Atrial Appendage Sealing Performance of the Amplatzer Amulet and Watchman FLX Device: A Head-to-Head Comparison</a></b><br />
<br />
12:00PM—12:12PM EDT<br />
<br />
This session will introduce data on the first head-to-head study of WATCHMAN FLX vs Amplatzer Amulet assessing LAA seal for both devices using CT imaging at eight weeks.<br />
<br />
Moderated Poster Presenter: Kasper Korsholm, MD<br />
<br />
Moderators: Maurice Buchbinder, MD; Carlos E. Sanchez, MD<br />
<br />
Discussants: Brijeshwar Maini, MD; Ramon Quesada, MD; Ruby Satpathy, MD]]></description>
            <dc:creator>ln108</dc:creator>
            <category>AFIBBERS FORUM</category>
            <pubDate>Wed, 27 Oct 2021 23:13:48 +0000</pubDate>
        </item>
        <item>
            <guid>https://www.afibbers.org/forum/read.php?9,182966,182968#msg-182968</guid>
            <title>Re: Abbott Amulet Update?</title>
            <link>https://www.afibbers.org/forum/read.php?9,182966,182968#msg-182968</link>
            <description><![CDATA[ [<a href="https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.057063"  rel="nofollow">www.ahajournals.org</a>]]]></description>
            <dc:creator>Poppino</dc:creator>
            <category>AFIBBERS FORUM</category>
            <pubDate>Tue, 26 Oct 2021 17:08:39 +0000</pubDate>
        </item>
        <item>
            <guid>https://www.afibbers.org/forum/read.php?9,182966,182966#msg-182966</guid>
            <title>Abbott Amulet Update?</title>
            <link>https://www.afibbers.org/forum/read.php?9,182966,182966#msg-182966</link>
            <description><![CDATA[ I&#039;m wondering if anyone has any knowledge of the latest thinking about the Abbott Aplatzer Amulet LAA ocluder device. I just noticed this press release (dated Aug. 16, 2021) from Abbott: <br />
<br />
<a href="https://abbott.mediaroom.com/2021-08-16-Abbotts-Amplatzer-TM-Amulet-TM-Device-Approved-by-FDA-to-Treat-People-With-Atrial-Fibrillation-at-Risk-of-Stroke"  rel="nofollow">Abbott&#039;s Amplatzer Amulet Device Approved by FDA</a><br />
<br />
In view of recent (and earlier) discussions on this forum about post-Watchman aspirin/NOAC use, am particularly curious about their claim, &quot;Before this approval, the only minimally invasive option for LAA occlusion for U.S. physicians and their patients was a solution with a single component to seal the LAA that requires blood-thinning drugs to heal and additional patient monitoring to ensure closure. In contrast, Abbott&#039;s Amulet uses dual-seal technology to completely and immediately seal the LAA. Amulet recipients do not need to use blood-thinning medication following the procedure.&quot;<br />
<br />
Thanks and best wishes, Lance]]></description>
            <dc:creator>ln108</dc:creator>
            <category>AFIBBERS FORUM</category>
            <pubDate>Tue, 26 Oct 2021 14:42:49 +0000</pubDate>
        </item>
    </channel>
</rss>
